Biosimilars and Switching: What Is Your Perspective?
The licensing of biosimilars heralds the start of a new era for physicians treating immune and inflammatory diseases. This symposium provided an update on biosimilar drugs and dealt with questions and concerns around switching from a reference biological drug to its biosimilar. Prof Isaacs presen...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2017-08-01
|
| Series: | European Medical Journal Rheumatology |
| Subjects: | |
| Online Access: | https://www.emjreviews.com/rheumatology/symposium/biosimilars-and-switching-what-is-your-perspective/ |